Now Approved! Available early 2017
EMFLAZA™ (deflazacort) is indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older.
For more information on getting started with EMFLAZA, please call 1‑844‑EMFLAZA (1‑844‑363‑5292)
8 am – 8 pm EST Monday – Friday to speak with a dedicated nurse case manager.
Register for updates
To receive updates and information about EMFLAZA, please complete the fields below.
To learn more about Marathon Pharmaceuticals, LLC, please visit marathonpharma.com